Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Respondent of NAD inquiry, marketer of Xenadrine EFX is Cytodyne LLC, not Cytodyne, as recently reported (1"The Tan Sheet" March 15, 2004, In Brief). The original Cytodyne licensed rights to its products to newly created entity Cytodyne LLC, a subsidiary of Phoenix Labs, in 2003 (2"The Tan Sheet" June 23, 2003, p. 13). The entity formerly known as Cytodyne is now called Nutraquest, which was not involved in the events related to the NAD inquiry...

Related Content

Cytodyne Products’ Distribution And Sales Rights Licensed To Phoenix Labs





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts